Review links aortic repair to lower mortality but higher stroke risk
Pooled studies of uncomplicated type B aortic dissection linked endovascular repair to fewer deaths but more strokes.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Endovascular repair was associated with lower all-cause mortality and higher stroke risk than optimal medical therapy. These competing outcomes matter when assessing the comparison. Because the abstract gives little detail about the included studies, it cannot establish causation or identify the better option for an individual patient.
The abstract omits study designs, follow-up lengths and absolute event rates. These gaps limit assessment of bias, timing and the mortality–stroke trade-off for patients.
What researchers found
All-cause mortality risk ratio
All-cause death risk with TEVAR was 0.57 times the risk with optimal medical therapy; follow-up duration not reported.
Stroke risk ratio
Stroke risk with TEVAR was 1.56 times the risk with optimal medical therapy; follow-up duration not reported.
Other outcomes remained uncertain
No statistically significant differences were detected for aortic rupture, repeat endovascular procedures, retrograde type A dissection or heart attack. These results do not establish equivalent safety alongside the higher pooled stroke risk.
Relative risks need context
Risk ratios describe relative differences between groups, not percentage-point changes in event probability. Without absolute event rates, the abstract cannot show how many patients experienced either outcome.
The original publication
Long term outcomes of thoracic endovascular repair versus optimal medical therapy for uncomplicated Stanford type B aortic dissection: a systematic review and meta-analysis.
Qazi SU, Zaide DB, Fatima U et al.
Future Cardiol · 2025
- PubMed ID
- 40923587
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.